Kolon TissueGene, Inc.
A clinical-stage biopharma developing cell and gene therapies for orthopedic diseases.
950160 | KO
Overview
Corporate Details
- ISIN(s):
- KR8840120008
- LEI:
- Country:
- United States of America
- Address:
- 9713 Key West Ave Suite 300, Rockville
- Website:
- https://www.tissuegene.com/
- Sector:
- Manufacturing
Description
Kolon TissueGene, Inc. is a clinical-stage biopharmaceutical company specializing in the development of advanced cell and gene therapies for orthopedic diseases and degenerative disorders. The company's lead product candidate, TG-C, is a first-in-class, allogeneic cell and gene therapy designed to treat knee osteoarthritis. The therapy aims to reduce pain, improve joint function, and slow the progression of the disease. TG-C is currently in late-stage clinical development, undergoing Phase 3 trials.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-03-21 00:00 |
감사보고서제출
|
Korean | 18.5 KB | ||
| 2022-03-21 00:00 |
사업보고서 (2021.12)
|
Korean | 1.2 MB | ||
| 2022-03-14 00:00 |
주주총회소집공고
|
Korean | 118.4 KB | ||
| 2022-02-10 00:00 |
주주총회소집결의
|
Korean | 10.1 KB | ||
| 2022-02-07 00:00 |
기타시장안내(코스닥시장위원회 개최 결과 및 심의속개 결정 안내)
|
Korean | 3.4 KB | ||
| 2022-01-07 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.6 KB | ||
| 2022-01-07 00:00 |
기타시장안내(개선계획 이행내역서 제출)
|
Korean | 3.5 KB | ||
| 2021-12-17 00:00 |
기타시장안내(개선기간 종료에 따른 상장폐지여부 결정 안내)
|
Korean | 3.8 KB | ||
| 2021-12-16 00:00 |
기타경영사항(자율공시)(제23기 정기주주총회 권리주주 확정을 위한 증권예탁증권 기준일 설정 공고)
|
Korean | 5.1 KB | ||
| 2021-12-15 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 120.9 KB | ||
| 2021-12-15 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.2 KB | ||
| 2021-12-15 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.2 KB | ||
| 2021-12-15 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 26.1 KB | ||
| 2021-12-10 00:00 |
증권발행결과(자율공시)(제3자배정 유상증자)
|
Korean | 5.8 KB | ||
| 2021-12-03 00:00 |
투자판단관련주요경영사항(TG-C 추가 적응증 미국FDA 임상2상 검토(Review) 완료 )
|
Korean | 11.8 KB |
Automate Your Workflow. Get a real-time feed of all Kolon TissueGene, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Kolon TissueGene, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Kolon TissueGene, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
